This summer, Ana Velázquez Mañana, MD, fellow in Medical Oncology, led UCSF’s first class of medical students from groups underrepresented in medicine.
The Helen Diller Family Comprehensive Cancer Center (HDFCCC) at UCSF was invited to participate in a national Pilot Project testing a research site self-assessment tool focused on increasing racial and ethnic diversity among cancer treatment trial participants.
In response to the recent adoption of the Texas Heartbeat Act (SB8) banning nearly all abortions, the Cancer Center’s Breast Oncology Program members are part of a growing effort to move the annual San Antonio Breast Cancer Symposium (SABCS) out of Texas.
Twitter’s reach and ability to influence have made it a critical communication tool in all areas of life and work. Learn how UCSF cancer experts are harnessing the value of Twitter's bite-sized benefits.
The idea of using cells as medicine emerged with bone marrow transplants, and then CAR-T therapy for blood cancers. Now, scientists are beginning to engineer much more complex living therapeutics by tapping into the innate capabilities of living cells to treat a growing list of diseases.